Bivalirudin

How is Bivalirudin dosed?

The dosage of bivalirudin is typically determined by a healthcare professional based on the individual patient's medical condition, age, and response to treatment. For adults, the usual dosage is 0.25 to 0.75 mg/kg of body weight, administered as an intravenous infusion over 1 to 2 hours. However, the exact dosage for a patient should be determined by a healthcare professional familiar with the patient's medical history and current condition.

What is the dosage form of Bivalirudin?

Bivalirudin is available in the following dosage forms: Solution and Powder for Solution.

What medications are contraindication with Bivalirudin?

Bivalirudin should not be used in patients with bleeding problems. Caution should be exercised when using bivalirudin in patients undergoing brachytherapy (a radiation treatment) as it may increase the risk of blood clots. Consult a healthcare professional for more information on contraindicated medications when using bivalirudin.

How is Bivalirudin administered?

Bivalirudin is administered by a healthcare professional through a needle placed into a vein. It is given together with aspirin to decrease the clotting ability of the blood and to help prevent harmful clots from forming in the blood vessels. This medicine is available only with a doctor's prescription and is used in patients undergoing certain heart and blood vessel procedures, such as coronary angioplasty.

What are common precautions when taking Bivalirudin?

Common precautions when taking bivalirudin include:

  1. Bleeding problems: Bivalirudin may increase the chance of bleeding. Inform your doctor if you have any bleeding problems or are taking any medications that may increase your risk of bleeding.
  2. Allergies: Inform your doctor if you have had any allergic reactions to bivalirudin or any other medications in the past.
  3. Kidney disease: Use with caution if you have kidney disease, as the dosage may need to be adjusted.
  4. Brachytherapy: Bivalirudin may increase the risk of blood clots when used with brachytherapy. Inform your doctor if you are undergoing this radiation treatment.
  5. Surgery: Inform your doctor if you are scheduled for surgery, as bivalirudin may increase the risk of bleeding during and after surgery.

Follow your doctor's instructions and keep all appointments for regular check-ups to monitor any potential side effects or complications.